CARGO Therapeutics, Inc.'s market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; CARGO Therapeutics, Inc. is scheduled to report earnings on March 21, 2024, and the estimated EPS forecast is $-1.62. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Jun 23	Dec 22
Income Statement	-
Total Revenue	$ 10.00K	-	-
Gross Profit	$ 10.00K	-	-
EBIT	$ -31.64M	-	-
EBITDA	$ -30.57M	-	-
Net Income Common Stockholders	$ -32.08M	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 405.70M	$ 42.37M	$ 1.87M
Total Assets	$ 453.04M	$ 60.50M	$ 10.24M
Total Debt	$ 28.54M	$ 3.47M	$ 23.35M
Net Debt	$ -377.16M	$ -38.90M	$ 21.48M
Total Liabilities	$ 47.65M	$ 29.31M	$ 45.48M
Stockholders Equity	$ 405.39M	$ 31.19M	$ -35.24M
Cash Flow	-
Free Cash Flow	$ -31.62M	-	-
Operating Cash Flow	$ -29.00M	-	-
Investing Cash Flow	$ -2.97M	-	-
Financing Cash Flow	$ 377.91M	-	-

Currency in USD

CARGO Therapeutics, Inc. Earnings and Revenue History

Income Statement >

CARGO Therapeutics, Inc. Debt to Assets

Balance Sheet >

CARGO Therapeutics, Inc. Cash Flow

Cash Flow >

CARGO Therapeutics, Inc. Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing